Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics for Fingertip Amputation
NCT02077400Completed
- Sponsor
- Emek Medical Center
- Start
- Jan 2006
- Primary completion
- Feb 2015
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of cefazolin in Wound infection (WI) (2 arms), sponsored by Emek Medical Center. Primary endpoint: Infection rate at 1 month. Started Jan 2006; status: completed.
02
Drugs
cefazolin
03
Conditions
Wound infection (WI)
Beyond the preview
Go deeper on NCT02077400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02077400.